comparemela.com
Home
Live Updates
Navrogen Enters into CRADA with The U.S. National Cancer Ins
Navrogen Enters into CRADA with The U.S. National Cancer Ins
Navrogen Enters into CRADA with The U.S. National Cancer Institute for the Clinical Development of NAV-001, an Anti-Mesothelin Antibody-Drug Conjugate
/PRNewswire/ -- Navrogen, Inc. announced today that it has entered into a Cooperative Research and Development Agreement (CRADA) with researchers at the U.S....
Related Keywords
Philadelphia ,
Pennsylvania ,
United States ,
Ira Pastan ,
Nicholas Nicolaides ,
Steven Kyriakos ,
Luigi Grasso ,
Raffit Hassan ,
Development Agreement ,
Us National Cancer Institute ,
Navrogen Incorporated ,
Laboratory Of Molecular Biology ,
Gi Malignancies Branch ,
Navrogen Inc ,
National Institutes Of Health ,
Cancer Research Laboratory Of Molecular Biology ,
Cooperative Research ,
Cancer Institute ,
National Institutes ,
Distinguished Investigator ,
Cancer Research ,
Molecular Biology ,
Deputy Chief ,
Chief Scientific Officer ,
Humoral Immuno Oncology ,
Chief Executive Officer ,
Navrogen ,
Ncorporated ,